Skip to main content
. 2022 May 24;9:846873. doi: 10.3389/fnut.2022.846873

TABLE 3.

Grade of fatty liver during VSL#3® treatment at baseline and after 3 months.

Placebo
VSL#3®
Baseline
3 months
Baseline
3 months
N 30 30 30 30
Grade 1, n (%) 16 (53.3) 14 (46.7) 19 (63.3) 5 (16.7)°**
Grade 2, n (%) 10 (33.3) 10 (33.3) 8 (26.7) 5 (16.7)*^
Grade 3, n (%) 4 (13.3) 4 (13.3) 3 (10.0) 2 (6.7)

Data are expressed as number or percentage. *p < 0.05 vs. baseline;°p < 0.01 vs. baseline; p < 0.05 vs. placebo; **p < 0.01 vs. placebo.